Back to search results

Regulating Together for Emotion Dysregulation in Autism and Intellectual Disability

This study is testing a group behavioral therapy called "Regulating Together" for children aged 8 to 12 who have both autism spectrum disorder (ASD) and an intellectual disability. The therapy uses relaxation techniques, parent training, and mindfulness to help manage strong emotions like irritability and aggression. The goal is to see if this adapted therapy can improve how children with ASD and intellectual disability manage their emotions. Researchers will measure changes in emotion regulation using a tool called the Emotion Dysregulation Inventory - Reactivity, from when you enroll until about 10 weeks after therapy ends. The study aims to enroll up to 10 children and their caregivers. The current status of the study is unclear.

Study design
This is an interventional study with up to 10 participants. It is designed to develop and test a behavioral therapy.
What's involved
Participants will attend twice-weekly 90-minute therapy sessions for 5 weeks. There will be five assessment visits: screening, baseline, post-treatment, and two follow-up appointments at 5 and 10 weeks after treatment.
Compensation
Not stated in the trial record.
Follow-up
Participants will have follow-up appointments 5 weeks and 10 weeks after the intervention ends.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07624448

Regulating Together for Intellectual Disability and Autism: A Group Behavioral Therapy for for Emotion Dysregulation

Recruiting
NAAges 8–12InterventionalTreatment
Children's Mercy Hospital Kansas City
~10 participants
Updated 2026-06-05 on ClinicalTrials.gov
What's tested:Regulating Together group therapy

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Emotion Dysregulation Inventory - Reactivity
Measured over From enrollment to the end of their follow up appointment, about 10 weeks after therapy has completed

Conditions

Autism
Intellectual Disabilities With Other Behavioral Symptoms
Intellectual Disability

Explore related trials

Autism Spectrum DisorderIntellectual Disability

Where it's being run

1 sites across 1 states
Missouri1

Study leadership

  • Walker McKinney, PhD · PRINCIPAL_INVESTIGATOR · Children's Mercy

Who to contact

Grayson Manley, RN
[email protected]
816-816-6967
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Males, females, or non-binary youth between 8 and 12 years of age
Confirmed diagnosis of Autism Spectrum Disorder (ASD)
Confirmed diagnosis of Intellectual Disability
Fluent in spoken English.
Use of flexible phrase speech or greater
Meeting clinically significant emotion dysregulation criteria
Willing to participate in twice weekly 90-minute sessions
Family is willing to keep prescribed psychiatric medication and outside behavioral interventions stable
Parent, guardian, or legally authorized representative (LAR) must provide written permission on behalf of the participant
Age ≥ 18 years
Lives and cares for their child with ASD+ID for \> 50% of the year
Fluent in spoken English.
Willing to participate in twice weekly 90-minute sessions, including one virtual session weekly

Exclusion

Initiation of new psychosocial intervention within 30 days prior to first day of treatment
Presence of physical aggression in the child directed towards a peer outside the home (i.e., non-siblings) that resulted in injury within 30 days prior to screening. Other significant disruptive, aggressive, self-injurious, or sexually inappropriate behavior felt to be dangerous or overly disruptive to the group sessions will be reviewed by the study team on an individual basis.
Presence of comorbid major neuropsychiatric illness warranting other treatment approaches
Presence of any major sensory impairment that would limit participating in the material including blindness or uncorrected hearing loss
Presence of any major sensory impairment that would limit participating in the material including blindness or uncorrected hearing loss

What this trial measures

  • Emotion Dysregulation Inventory - ReactivityFrom enrollment to the end of their follow up appointment, about 10 weeks after therapy has completed

    The Emotion Dysregulation Inventory consists of two subscales. The investigators will use the Reactivity subscale which captures poorly regulated negative emotional responses and a dysphoria subscale characterized by increased negative affect and lack of motivation. Minimum raw score: 0; Maximum raw score: 96; Higher scores reflect higher emotional reactivity.